INTC: A Gap-Down Needs More Than an Oversold RSI to RepairIntel CorporationBATS:INTCSmalldikenergyMy Intel lean is bearish while the completed daily chart sits below a falling 55 EMA and leaves a large gap overhead. The business question is just as specific: how much of the foundry segment's reported revenue comes from external customers, and how repeatable is the increase? A large segment total and a repaired stock chart would answer different questions. This review uses Intel's October 29 release and the quarter ended September 26, 2026. The genuine native daily chart ends with October 30; the options snapshot is the provider's last available weekend data. A Saturday research and export time does not create another completed stock session. No position, order or fill is represented. MACRO: FINANCING CONDITIONS ARE CONTEXT, NOT A REVENUE BRIDGE The Federal Reserve held its policy range at 3.75%–4.00% on October 28. The dated policy decision matters as a financing backdrop for a capital-intensive manufacturing business, but it does not quantify Intel's actual borrowing expense, factory utilization or demand. Those conclusions require the company's disclosures and their relevant periods. The next scheduled macro checkpoint is September JOLTS on November 3 at 9:00 a.m. CST, followed by preliminary Q3 Productivity and Costs on November 5 at 7:30 a.m. CST and October Employment Situation on November 6 at 7:30 a.m. CST. Those times account for the November 1 clock change. Their results remain unknown here. From the index to the sector to this stock, I would keep the questions separate. Broad financial conditions can change the valuation discussion. Semiconductor demand and manufacturing economics then need their own evidence. A company-specific price gap should not be explained away merely because the next macro release might be favorable. FUNDAMENTAL: IDENTIFY WHO IS BUYING THE OUTPUT Intel reported Q3 foundry segment revenue of $6,697 million. Its filing identifies $411 million of external foundry revenue, versus $32 million in the prior-year quarter. The $379 million increase was primarily associated with revenue recognized under a non-recurring foundry contract. Segment revenue consists substantially of intersegment product and service sales. The arithmetic puts external revenue at about 6.14% of the segment total. Subtracting it leaves $6,286 million; that is an arithmetic remainder, not a new reported revenue category. Internal segment sales and the related eliminations need reconciliation at the consolidated level. The segment total must not be relabeled as sales to outside foundry customers. That distinction changes what I would ask management to demonstrate next. If the thesis depends on a durable external manufacturing business, I want evidence of repeatable customer demand, economic utilization and the conversion of that activity into returns. Growth in an internal accounting measure is not enough to settle those questions. A non-recurring contribution does not make all future activity worthless, and it does not establish that the same amount disappears next quarter. It means a simple annualization would carry an assumption that has not been demonstrated. My question is how much of the activity can repeat under comparable economics, rather than how large a headline growth percentage can be made to look. The small prior-year external base also makes percentage growth a poor substitute for scale. A large multiple of a small denominator can coexist with external sales remaining a small portion of the broader segment. That observation is arithmetic, not an estimate of external market share or a forecast of future customer wins. I would not use the 6.14% ratio as a margin, a cash-conversion rate or an ownership percentage. Its numerator and denominator are revenues with different customer scope. It is useful because it describes that scope. It does not measure the profit earned on the external business, its capital requirements or the cash already collected. TECHNICAL: A FAILED REBOUND LEAVES A NEW DECISION ZONE The native daily series shows the October 30 open at $68.36, high $68.77, low $63.2001 and close $65.76. The 55 EMA is approximately $99.94 and RSI approximately 25.10. The stock is below a falling trend average. A low oscillator reading describes weakness; it does not establish that the decline must reverse on the next bar. The chart labels A at the October 2 high of $126.00, B at the October 22 low of $84.645, C at the October 28 high of $95.68 and D at the October 30 low of $63.2001. C is a lower high after the earlier decline. D is the current measured endpoint, not a confirmed reversal swing with future bars already known. The October 30 high is below the October 29 low of $90.838, leaving an unfilled daily gap between $68.77 and $90.838 in this series. The chart draws those two boundaries and the descending A-to-C guide. It does not force a flag, triangle or Elliott count where the observed candles do not establish one. The October 29 earnings date is context, not proof that this one accounting distinction alone caused the price move. The Fibonacci study measures the decline from A, $126.00, to D, $63.2001, a range of $62.7999. With the chart's reversed high-to-low convention, the displayed 0.786 level is $76.6393 and 0.618 is $87.1897. Those are recovery checkpoints inside the measured decline, not percentages of company value or evidence that a recovery has occurred. Extending that same measured range to 1.272 produces $46.1185. This is a conditional mathematical extension, not a forecast of where the stock must trade. The current low, $63.2001, remains the first downside boundary. Its role is the break-and-reclaim test itself; it is not silently presented as a separate lower target beyond the trigger. WHAT WOULD CHANGE THE BEARISH ASSESSMENT? A bullish repair needs a daily break and close above $68.77, then a separate retest that holds. The two upside checkpoints are $76.64 and $87.19. A return below $65 defeats the immediate repair; acceptance below $63 defeats the wider bullish attempt. Even reaching the second recovery checkpoint would leave the far gap edge and the prior lower high as further unresolved context. For bearish continuation, require a daily break and close below $63.2001 and then a separate failed reclaim. The downside map is the $63.2001 boundary followed by the $46.12 extension. A held recovery above $68.77 invalidates that local bearish attempt, while sustained acceptance above $95.68 invalidates the wider lower-high thesis. These conditions require separate observations, not an opening print or a touch of a line. OPTIONS: KEEP THE PROVIDER'S WALL IDENTITIES INTACT Tanuki's selected November 6 cumulative INTC scope identifies put wall P1 at $65 and call wall C1 at $63. Those walls, the two upside checkpoints and the two distinct downside decision prices make the six-level map. The inverted wall order is preserved. Neither the word put nor the word call makes a concentration a guaranteed support or resistance response. The provider labels the profile Negative Gamma and HVL at $91. HVL remains its Highest Volatility Level context; the source does not establish it here as a verified zero-gamma flip. The saved snapshot is October 31 at 15:00:05 CDT, with weekend updates paused. The native export generated at 23:21:45 CDT contains INTC-only data across 18 expiries; the chart uses the selected November 6 cumulative row. The chart close of $65.76 and Tanuki's displayed reference of $65.37 have different source bases. I have not combined them into one common daily return. Export time, page refresh time and saved-data time are also different records. Recheck price, expiry scope and concentrations in the next liquid session before relying on this weekend map. The practical risk is a gap or fast move through a planned level before a separate retest can be assessed. Spreads, slippage and position size still matter even if the analytical direction is right. Research and education only. Would you require repeatable external-customer evidence and a separate held reclaim of $68.77 before changing the bearish assessment, or would the foundry segment headline alone change your view?